Seres Therapeutics, Inc. (MCRB)
17.16
+0.18
(+1.06%)
USD |
NASDAQ |
Dec 11, 16:00
17.24
+0.08
(+0.47%)
After-Hours: 20:00
Seres Therapeutics EPS Diluted (Quarterly): 0.9353 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
| NanoViricides, Inc. | -0.1045 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 8.204M |
| Revenue (Quarterly) | 0.351M |
| Total Expenses (Quarterly) | -7.853M |
| Enterprise Value | 187.84M |
| Gross Profit Margin (Quarterly) | -197.4% |
| Earnings Yield | 3.54% |
| Normalized Earnings Yield | 3.537 |